AtriCure to Participate at Upcoming Investor Conferences
Business Wire•26/10/2026•08:00 ET
0
Key Highlights
- ➤AtriCure will participate in UBS Global Healthcare Conference on November 9, 2026.
- ➤AtriCure will participate in Stifel Healthcare Conference on November 11, 2026.
- ➤Management fireside discussions scheduled at both upcoming investor conferences.
Expert Statements
Angie Wirick, Chief Financial Officer of AtriCure, Inc.
“Angie Wirick”
AtriCure, Inc. (Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in two upcoming investor conferences.
AtriCure’s management is scheduled to participate in a fireside discussion on Monday, November 9, 2026, at 11:00 a.m. Eastern Standard Time at the UBS Global Healthcare Conference.
Get started
Create a free account to read the full story.